FDA 483 - Michigan Reproductive and IVF Center, PLLC - April 27, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Michigan Reproductive and IVF Center, PLLC in Grand Rapids, MI, revealed significant deficiencies in donor screening practices for reproductive human tissue. The firm failed to adequately screen oocyte and semen donors for communicable disease agents, specifically by omitting physical examinations of the pelvic and reproductive organ areas. Additionally, the firm deemed a donor eligible despite an incomplete screening history and a reactive Hepatitis B test, indicating a failure to properly assess donor eligibility.
ID · 62fd22e5-f19f-4500-981c-fd27ac336e2d